Shanghai Pharmaceuticals Holding Co., Ltd (HKG:2607)
Hong Kong
· Delayed Price · Currency is HKD 11.04
+0.02 (0.18%)
May 14, 2025, 1:45 PM HKT
HKG:2607 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 13, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 65,574 | 73,849 | 61,812 | 67,912 | 60,487 | 56,403 | Upgrade
|
| Market Cap Growth | 6.98% | 19.47% | -8.98% | 12.28% | 7.24% | 5.52% | Upgrade
|
| Enterprise Value | 94,488 | 101,687 | 88,205 | 91,655 | 94,149 | 84,943 | Upgrade
|
| Last Close Price | 11.02 | 12.62 | 10.90 | 11.84 | 12.94 | 11.53 | Upgrade
|
| PE Ratio | 14.08 | 15.24 | 14.89 | 10.69 | 9.68 | 10.56 | Upgrade
|
| PS Ratio | 0.22 | 0.25 | 0.22 | 0.26 | 0.23 | 0.25 | Upgrade
|
| PB Ratio | 0.72 | 0.83 | 0.70 | 0.77 | 0.83 | 0.87 | Upgrade
|
| P/TBV Ratio | 1.09 | 1.26 | 1.10 | 1.21 | 1.54 | 1.65 | Upgrade
|
| P/FCF Ratio | 8.95 | 20.25 | 24.82 | 29.18 | 52.28 | 12.39 | Upgrade
|
| P/OCF Ratio | 6.72 | 11.91 | 10.73 | 12.67 | 9.74 | 6.94 | Upgrade
|
| EV/Sales Ratio | 0.32 | 0.35 | 0.31 | 0.35 | 0.36 | 0.37 | Upgrade
|
| EV/EBITDA Ratio | 8.05 | 9.30 | 7.94 | 8.37 | 8.55 | 8.15 | Upgrade
|
| EV/EBIT Ratio | 10.15 | 10.92 | 9.33 | 9.93 | 10.27 | 9.82 | Upgrade
|
| EV/FCF Ratio | 12.89 | 27.89 | 35.41 | 39.39 | 81.38 | 18.65 | Upgrade
|
| Debt / Equity Ratio | 0.70 | 0.65 | 0.65 | 0.57 | 0.69 | 0.67 | Upgrade
|
| Debt / EBITDA Ratio | 5.48 | 4.97 | 4.82 | 4.29 | 4.24 | 3.90 | Upgrade
|
| Debt / FCF Ratio | 8.69 | 15.95 | 22.96 | 21.67 | 43.25 | 9.58 | Upgrade
|
| Asset Turnover | 1.25 | 1.27 | 1.27 | 1.28 | 1.38 | 1.34 | Upgrade
|
| Inventory Turnover | 6.87 | 6.48 | 6.45 | 6.55 | 7.32 | 6.77 | Upgrade
|
| Quick Ratio | 1.04 | 1.02 | 0.98 | 0.99 | 0.93 | 0.90 | Upgrade
|
| Current Ratio | 1.36 | 1.36 | 1.33 | 1.35 | 1.27 | 1.22 | Upgrade
|
| Return on Equity (ROE) | 6.74% | 7.16% | 6.53% | 10.20% | 11.03% | 10.77% | Upgrade
|
| Return on Assets (ROA) | 2.42% | 2.52% | 2.61% | 2.82% | 2.99% | 3.18% | Upgrade
|
| Return on Capital (ROIC) | 3.81% | 4.04% | 4.21% | 4.59% | 4.88% | 5.19% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.00% | 9.20% | 9.60% | 9.30% | 10.40% | 11.90% | Upgrade
|
| Earnings Yield | 7.10% | 6.56% | 6.72% | 9.35% | 10.34% | 9.47% | Upgrade
|
| FCF Yield | 11.18% | 4.94% | 4.03% | 3.43% | 1.91% | 8.07% | Upgrade
|
| Dividend Yield | 4.79% | 3.12% | 4.14% | 5.83% | 3.98% | 4.94% | Upgrade
|
| Payout Ratio | 81.44% | 79.16% | 105.66% | 55.08% | 52.54% | 53.79% | Upgrade
|
| Buyback Yield / Dilution | -0.48% | -0.07% | -6.28% | -22.54% | - | - | Upgrade
|
| Total Shareholder Return | 4.31% | 3.04% | -2.13% | -16.72% | 3.98% | 4.94% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.